Press Enter to search · ESC to close

Macro

China Adds WuXi Biologics’ CAR-T Therapy Relma-cel to National Insurance

China’s National Healthcare Security Administration said on Nov. 14 that relma-cel, a CAR-T therapy from JW Therapeutics, has been added to the national medical insurance list. Before inclusion, relma-cel was priced at 1.29 million yuan per infusion. Ma Jun, director of the Harbin Institute of Hematology and Oncology, who took part in the drug’s review and clinical-use consensus, said the price has fallen below 300,000 yuan per infusion following the listing.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback